{"id":4072,"date":"2020-07-14T15:22:41","date_gmt":"2020-07-14T12:22:41","guid":{"rendered":"http:\/\/pre.vitroturkey.bio\/vitro-releases-a-new-in-vitro-diagnostic-test-for-the-simultaneous-detection-of-the-virus-of-the-covid-19-and-other-20-respiratory-pathogens\/"},"modified":"2022-02-15T01:48:25","modified_gmt":"2022-02-14T22:48:25","slug":"vitro-covid-19-virusu-ve-20-diger-solunum-yolu-patojeninin-es-zamanli-tespiti-icin-yeni-bir-in-vitro-tani-testi-piyasaya-surdu","status":"publish","type":"post","link":"https:\/\/vitroturkey.bio\/tr\/vitro-covid-19-virusu-ve-20-diger-solunum-yolu-patojeninin-es-zamanli-tespiti-icin-yeni-bir-in-vitro-tani-testi-piyasaya-surdu\/","title":{"rendered":"Vitro, COVID-19 vir\u00fcs\u00fc ve 20 di\u011fer solunum yolu patojeninin e\u015f zamanl\u0131 tespiti i\u00e7in yeni bir in vitro tan\u0131 testi piyasaya s\u00fcrd\u00fc."},"content":{"rendered":"<ul>\n<li><strong>\u201cSolunum Flow \u00c7ipi\u201d m\u00fcltipleks testi, te\u015fhis laboratuvarlar\u0131n\u0131n, solunum yolu enfeksiyonuna neden olan vir\u00fcs veya bakteriyi tek bir numuneden tan\u0131mlamas\u0131n\u0131 sa\u011flar.<\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong>Vitro S.A., SARS-CoV-2 dahil olmak \u00fczere, b\u00f6ylesine b\u00fcy\u00fck bir solunum yolu viral panelini kapsayan bir testi, d\u00fcnya \u00e7ap\u0131nda ticarile\u015ftiren ilk \u015firkettir.<\/strong><\/li>\n<\/ul>\n<p>In Vitro Diagnostic (IVD) cihazlar\u0131n\u0131n, yaz\u0131l\u0131mlar\u0131 ve reaktiflerinin geli\u015ftirilmesi, \u00fcretimi ve sat\u0131\u015f\u0131nda uzmanla\u015fm\u0131\u015f \u0130spanyol \u015firketler grubu Vitro SA, ayn\u0131 anda 21 solunum yolu patojenini tespit etmek i\u00e7in &#8220;Solunum Flow \u00c7ipi&#8221; adl\u0131 yeni bir In Vitro Diagnostic testi piyasaya s\u00fcrd\u00fc, bunlar 18 viral t\u00fcr, SARS-CoV 2 ve \u00fc\u00e7 bakteri t\u00fcr\u00fc. Bu \u015fekilde, b\u00f6ylesi b\u00fcy\u00fck bir solunum yolu viral panelini kapsayan bir testi ticarile\u015ftiren, d\u00fcnya \u00e7ap\u0131nda ilk \u015firket oldu.<\/p>\n<blockquote><p>SARS-CoV-2 ve ana akut solunum yolu enfeksiyonlar\u0131na neden olan di\u011fer 20 patojenin n\u00fckleik asitlerinin tan\u0131mlanmas\u0131na y\u00f6nelik bu yeni IVD kiti, olduk\u00e7a hassas ve spesifiktir.<\/p><\/blockquote>\n<p>Solunum yolu enfeksiyonuna neden olan vir\u00fcs\u00fcn tek bir laboratuvar testinde tespit edilmesine ve b\u00f6ylece tan\u0131 s\u00fcrelerinin k\u0131salt\u0131lmas\u0131na, hastal\u0131\u011fa neden olan vir\u00fcs\u00fcn t\u00fcr\u00fcne ba\u011fl\u0131 olarak hastan\u0131n izolasyonu karar\u0131n\u0131 kolayla\u015ft\u0131rd\u0131\u011f\u0131ndan \u00e7ok y\u00fcksek bir de\u011fere sahiptir.<\/p>\n<p>Vitro taraf\u0131ndan \u00fcretilen test, COVID-19 oldu\u011fundan \u015f\u00fcphelenilen ki\u015filerden al\u0131nan nazofaringeal yayma veya bronkoalveolar lavaj numuneleri \u00fczerinde ger\u00e7ekle\u015ftirilir. Numune, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 taraf\u0131ndan \u201cSolunum Flow \u00c7ipi\u201d kiti ile topland\u0131ktan sonra te\u015fhis laboratuvarlar\u0131nda h\u0131zl\u0131 ve tam otomatik bir \u015fekilde i\u015flenir. Bu test, incelenen 21 patojene \u00f6zg\u00fc genom dizilerinin bulundu\u011fu yakalama \u00e7ipi dahil, numune muamelesi i\u00e7in gerekli t\u00fcm reaktifleri i\u00e7erir. Yeni test, SARS-CoV-2&#8217;yi saptaman\u0131n yan\u0131 s\u0131ra Influenza A vir\u00fcs\u00fc, \u0130nfluenza B vir\u00fcs\u00fc, Solunum Sinsitiyal Vir\u00fcs\u00fc, Rhinovir\u00fcs, Enterovir\u00fcs, \u0130nsan Parainfluenza Vir\u00fcs\u00fc, Adenovir\u00fcs, Metapneumovir\u00fcs ve Bordetella pertussis ve parapertussis ve Mycoplasma pneumoniae bakterilerini tespit eder.<\/p>\n<blockquote><p>&#8220;Solunum Flow \u00c7ipi&#8221; testi, PCR tekni\u011fini ve ters flow teknolojisini birle\u015ftiren robotik hybriSpotTM cihazlar\u0131 taraf\u0131ndan otomatik olarak i\u015flenir. Bu \u015fekilde, Vitro&#8217;nun yeni \u00fcr\u00fcn\u00fc, hastalardan al\u0131nan 24 numunenin ayn\u0131 anda analiz edilmesini sa\u011flayarak, sonu\u00e7 raporunu 3 saatten daha k\u0131sa bir s\u00fcrede verir.<\/p><\/blockquote>\n<p>hybriSpotTM platformlar\u0131, bu solunum yolu patojenlerinden ve \u00e7e\u015fitli hastal\u0131klara neden olan \u00e7oklu patojenlerin di\u011fer panellerinden genetik materyalin e\u015f zamanl\u0131 te\u015fhisi i\u00e7in \u00e7ok y\u00f6nl\u00fc, etkili ve ekonomik bir \u00e7\u00f6z\u00fcm sunar. Ayr\u0131ca bu robotlar, Vitro taraf\u0131ndan hybriSpotTM \u00fcr\u00fcn portf\u00f6y\u00fcn\u00fc olu\u015fturan t\u00fcm testler i\u00e7in y\u00f6netim ve analiz yaz\u0131l\u0131mlar\u0131n\u0131n da geli\u015ftirildi\u011fi Sevilla&#8217;daki tesislerinde geli\u015ftirilmekte ve \u00fcretilmektedir. Vitro, Granada&#8217;daki tesislerinde t\u00fcm testleri ve reaktifleri kendisi tasarlar ve \u00fcretir. Bu tan\u0131 platformlar\u0131 CE-IVD i\u015faretine sahiptir ve \u015fu anda hem \u0130spanya&#8217;da hem de 30&#8217;dan fazla \u00fclkede sat\u0131\u015fa sunulmu\u015ftur.<\/p>\n<blockquote><p>&#8220;Solunum Flow \u00c7ipi&#8221; testi, \u0130spanya&#8217;da Vitro taraf\u0131ndan sat\u0131\u015fa sunulan, COVID-19 ile sava\u015fmay\u0131 ama\u00e7layan \u00fc\u00e7\u00fcnc\u00fc tan\u0131 testidir. Sevilla&#8217;daki \u015firketler grubu, Carlos III Sa\u011fl\u0131k Enstit\u00fcs\u00fc taraf\u0131ndan %100 duyarl\u0131l\u0131k ve spesifiklikle do\u011frulanan SARS-CoV-2 n\u00fckleik asidini saptamak i\u00e7in bir RT-CPR testi geli\u015ftirdi ve sat\u0131\u015fa sundu.<\/p><\/blockquote>\n<p>Ek olarak ve Vitro&#8217;nun baz\u0131 yabanc\u0131 IVD platformlar\u0131 ve testleri \u00fcreticileri i\u00e7in se\u00e7ici olarak yapt\u0131\u011f\u0131 sat\u0131\u015f faaliyetine g\u00f6re, \u015firket tek yetkili olarak, \u0130spanya&#8217;da \u00c7inli \u00fcretici Snibe\u2019\u0131n SARS-CoV-2&#8217;ye kar\u015f\u0131 kanda IgM ve IgG antikorlar\u0131n\u0131n tespiti i\u00e7in seroloji bazl\u0131 testini satmaktad\u0131r. Yak\u0131n zamanda \u0130spanya&#8217;da, Genscript firmas\u0131 taraf\u0131ndan \u00fcretilen, SARS-CoV-2 n\u00f6tralize edici antikorlar\u0131n tespiti i\u00e7in kullan\u0131lan, sertifikal\u0131 ilk kit tan\u0131t\u0131ld\u0131 ve b\u00f6ylece seroloji bazl\u0131 test portf\u00f6y\u00fcn\u00fc de g\u00fc\u00e7lendirdi.<\/p>\n<p>Sa\u011fl\u0131k krizinin ilk \u00fc\u00e7 ay\u0131nda, Vitro taraf\u0131ndan sa\u011flanan ve Snibe taraf\u0131ndan \u00fcretilen COVID-19&#8217;a kar\u015f\u0131 kullan\u0131lan IgM ve IgG testleri \u0130spanya&#8217;daki sa\u011fl\u0131k ihtiyac\u0131n\u0131n %40&#8217;\u0131n\u0131 kar\u015f\u0131lam\u0131\u015ft\u0131r. Bu ba\u011flamda, Vitro SA CEO&#8217;su Javier Fernandez \u015funlar\u0131 s\u00f6yl\u00fcyor: &#8220;Granada&#8217;daki temel laboratuvar\u0131m\u0131z\u0131n altyap\u0131s\u0131 sayesinde, \u015fu anda yaln\u0131zca PCR teknolojilerini de\u011fil, \u00e7e\u015fitli teknolojileri, flow sitometri ve alternatif teknolojileri de kullanarak, SARS-CoV-2 i\u00e7in yenilik\u00e7i tan\u0131 testlerini do\u011fruluyoruz, ayn\u0131 zamanda hem vir\u00fcs\u00fcn RNA&#8217;s\u0131n\u0131n hem de vir\u00fcse kar\u015f\u0131 geli\u015ftirilen antikorlar\u0131n tespitini sa\u011fl\u0131yoruz. Bu da, Vitro&#8217;nun Covid-19 i\u00e7in farkl\u0131 te\u015fhis testleri ve teknolojileri geli\u015ftirme ve tedarik etme kapasitesini Ulusal Sa\u011fl\u0131k Sistemimizde benzersiz k\u0131l\u0131yor\u201d . Bu yeni te\u015fhis testleri yak\u0131nda kullan\u0131ma sunulacak ve \u0130spanya&#8217;n\u0131n hastane a\u011f\u0131n\u0131n SARS-CoV-2&#8217;ye kar\u015f\u0131 \u015fu anda mevcut olan en modern te\u015fhis ara\u00e7lar\u0131na sahip olmas\u0131n\u0131 sa\u011flayacak.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In Vitro Diagnostic (IVD) cihazlar\u0131n\u0131n, yaz\u0131l\u0131mlar\u0131 ve reaktiflerinin geli\u015ftirilmesi, \u00fcretimi ve sat\u0131\u015f\u0131nda uzmanla\u015fm\u0131\u015f \u0130spanyol \u015firketler grubu Vitro SA, ayn\u0131 anda 21 solunum yolu patojenini tespit etmek i\u00e7in &#8220;Solunum Flow \u00c7ipi&#8221; adl\u0131 yeni bir In Vitro Diagnostic testi piyasaya s\u00fcrd\u00fc, bunlar 18 viral t\u00fcr, SARS-CoV 2 ve \u00fc\u00e7 bakteri t\u00fcr\u00fc. Bu \u015fekilde, b\u00f6ylesi b\u00fcy\u00fck bir solunum yolu viral panelini kapsayan bir testi ticarile\u015ftiren, d\u00fcnya \u00e7ap\u0131nda ilk \u015firket oldu.<\/p>\n","protected":false},"author":18,"featured_media":4845,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"link","meta":[],"categories":[21,23,25],"tags":[],"_links":{"self":[{"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/posts\/4072"}],"collection":[{"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/comments?post=4072"}],"version-history":[{"count":1,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/posts\/4072\/revisions"}],"predecessor-version":[{"id":5595,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/posts\/4072\/revisions\/5595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/media\/4845"}],"wp:attachment":[{"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/media?parent=4072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/categories?post=4072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vitroturkey.bio\/tr\/wp-json\/wp\/v2\/tags?post=4072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}